Skip to main content

Table 3 Regression analysis between concentration of IgA, IgM and IgG anti-HP antibodies with EDSS, age and length of disease

From: Helicobacter pylori antibodies and multiple sclerosis: a single-center study and a short review of the literature

IgG (RU/ml)

Univariate

Multivariate

Coef

95% CI

Coef

95% CI

EDSSa

− 0.04

− 0.1 to 0.09

− 0.1

− 0.3 to 0.01

Age

− 0.4

− 1.3 to 0.4

− 0.81

− 1.7 to 0.1

Length of disease

0.1

− 0.9 to 1.3

− 0.3

− 1.2 to 1.1

IgM (RU/ml)

Univariate

Multivariate

Coef

95% CI

Coef

95% CI

EDSSa

− 0.1

− 0.2 to 0.1

− 0.1

− 0.2 to 0.06

Age

− 0.07

− 0.1 to -0.005

− 0.06

− 0.1 to 0.01

Length of disease

− 0.02

− 0.1 to 0.06

− 0.01

− 0.1 to 0.08

IgA (RU/ml)

Univariate

Multivariate

Coef

95% CI

Coef

95% CI

EDSSa

0.04

− 0.1 to 0.1

− 0.04

− 0.2 to 0.1

Age

− 0.0004

− 0.01 to 0.01

− 0.006

− 0.02 to 0.01

Length of disease

0.001

− 0.01 to 0.02

− 0.001

− 0.02 to 0.02

  1. Phenotype of multiple sclerosis, sex, and previous history of immunomodulatory agents were used as covariates for the multivariate analysis
  2. RU/ml Relative units per milliliter; EDSS Expanded disability status scale; Coef Regression coefficient; 95% CI 95% confidence interval
  3. aEDSS was considered as an ordinal variable and ordinal linear regression was conducted for this case